Cargando…
CD8α+ dendritic cells potentiate antitumor and immune activities against murine ovarian cancers
Dendritic cell (DC)-based immunotherapies have been shown to be a potential treatment option for various cancers; however, the exact strategies in ovarian cancer remain unknown. Here, we report the effectiveness of mouse CD8α+ DCs derived from bone marrow hematopoietic stem cells (BM-HSCs), equivale...
Autores principales: | Lee, Shin-Wha, Lee, Hyunah, Lee, Kyung-Won, Kim, Min-Je, Kang, Sung Wan, Lee, Young-Jae, Kim, HyunSoo, Kim, Yong-Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810613/ https://www.ncbi.nlm.nih.gov/pubmed/36596856 http://dx.doi.org/10.1038/s41598-022-27303-7 |
Ejemplares similares
-
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
por: Baek, Soyoung, et al.
Publicado: (2011) -
CD8α+ dendritic cells dictate immune responses against murine AML
por: Kline, Douglas E, et al.
Publicado: (2013) -
Host type I IFN signals are required for antitumor CD8(+) T cell responses through CD8α(+) dendritic cells
por: Fuertes, Mercedes B., et al.
Publicado: (2011) -
Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous Ovarian Cancer
por: Lee, Shin-Wha, et al.
Publicado: (2021) -
RORα Regulates Cholesterol Metabolism of CD8(+) T Cells for Anticancer Immunity
por: Lee, In Kyu, et al.
Publicado: (2020)